Sun Pharma’s $11.75 billion Organon deal adds scale and new markets, but higher debt and lower returns raise questions over its valuation premium.
Krishnadevan V
April 30, 2026 at 10:35 AM IST
Istock.com
Through buying domain depth across insurance, automotive, engineering, application services, and recently, food and agri-business, Wipro is either building an unusually broad capability mosaic or accumulating integration drag across multiple sectors at once.
Dev Chandrasekhar
April 17, 2026 at 10:52 AM IST
iStock.com